Sorrento Therapeutics, Inc. 4
4 · Sorrento Therapeutics, Inc. · Filed Jul 12, 2016
Insider Transaction Report
Form 4
EBERSOLE DOUGLAS O
Director
Transactions
- Award
Stock Options
2016-07-11+35,000→ 94,000 totalExercise: $6.44Exp: 2026-07-11→ Common Stock (35,000 underlying)
Footnotes (1)
- [F1]1/12 of the original number of shares subject to this option shall vest and become exercisable following each one month of service thereafter, subject to the reporting person's continued service on the issuer's board of directors on each such date.